Latest Period
Q2 2026
CUSIP: 87165D208
Latest Period
Q2 2026
Institutions Reporting
14
Shares (Excl. Options)
589,380
Price
$0.20
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 14 institutions filings for Q2 2026.
Security key
87165D208
Latest holder period
Q2 2026
13F holders
14
13D/G owners
1
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 87165D208:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Knight Therapeutics Inc | 20% | +17% | $3,536,116 | +$792,854 | 1,911,414 | +29% | KNIGHT THERAPEUTICS INC. | 11 Jun 2025 |
As of 30 Jun 2026, 14 institutional investors reported holding 589,380 shares of Synergy CHC Corp. - Common Stock, par value $0.00001 per share (SNYR). This represents 6.1% of the company’s total 9,605,095 outstanding shares.
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 589,380 | $116,587 | -$1,882,498 | $0.20 | 14 |
| 2026 Q1 | 1,675,838 | $2,158,605 | +$436,558 | $1.29 | 12 |
| 2025 Q4 | 1,297,093 | $2,412,592 | -$874,135 | $1.86 | 12 |
| 2025 Q3 | 1,640,098 | $4,001,535 | +$2,950,002 | $2.44 | 11 |
| 2025 Q2 | 427,288 | $1,217,771 | -$1,153,510 | $2.85 | 6 |
| 2025 Q1 | 905,310 | $2,128,805 | -$37,888 | $2.35 | 8 |
| 2024 Q4 | 911,017 | $4,046,331 | +$4,046,331 | $4.40 | 9 |